These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2511908)

  • 1. [Evaluation of bone atrophy by microdensitometry and effect of active vitamin D3 (1 alpha-OH-D3) administration in patients receiving anticonvulsants].
    Takeno Y
    No To Shinkei; 1989 Sep; 41(9):887-93. PubMed ID: 2511908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Osteopathy and therapeutic effect of 1 alpha-OH-D3 in severely handicapped children].
    Kimura A
    No To Hattatsu; 1991 May; 23(3):265-72. PubMed ID: 1828358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of anticonvulsant-induced bone changes by a microdensitometric method].
    Iwata Y; Amano K; Kawamura H; Tanikawa T; Kawabatake H; Notani M; Iseki H; Shiwaku T; Nagao T; Taira T
    No Shinkei Geka; 1985 Mar; 13(3):293-9. PubMed ID: 4010879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senile deafness and metabolic bone disease.
    Yamazaki T; Ogawa K; Imoto T; Hayashi N; Kozaki H
    Am J Otol; 1988 Sep; 9(5):376-82. PubMed ID: 3202126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microdensitometric study of maturation and fragility of the bone in male patients with cerebral palsy--the effect of long-term administration of 1 alpha-hydroxy vitamin D3 and the value of osteocalcin as a marker of bony growth].
    Hayashi Y; Araki K; Morioka N; Kurashige T; Shiraishi T; Ogura H; Tani J
    No To Hattatsu; 1990 May; 22(3):209-15. PubMed ID: 2363958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone mineral metabolism changes in epileptic children receiving valproic acid.
    Oner N; Kaya M; Karasalihoğlu S; Karaca H; Celtik C; Tütüncüler F
    J Paediatr Child Health; 2004 Aug; 40(8):470-3. PubMed ID: 15265190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of alfacalcidol (1 alpha-OH-D3) on post oophorectomy osteopenia as measured by microdensitometry].
    Ohta H; Nemoto K; Iizuka R
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):505-12. PubMed ID: 2754281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of valproic acid on bone mineral density and bone metabolism: A meta-analysis.
    Fan D; Miao J; Fan X; Wang Q; Sun M
    Seizure; 2019 Dec; 73():56-63. PubMed ID: 31756600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1 alpha-hydroxyvitamin D3 and calcium supplementation.
    Sato Y; Maruoka H; Oizumi K
    Stroke; 1997 Apr; 28(4):736-9. PubMed ID: 9099188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy.
    Triantafyllou N; Lambrinoudaki I; Armeni E; Evangelopoulos EM; Boufidou F; Antoniou A; Tsivgoulis G
    J Neurol Sci; 2010 Mar; 290(1-2):131-4. PubMed ID: 20056251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 1 alpha(OH)-vitamin D3 and 24,25(OH)2-vitamin D3 on long bones of glucocorticoid-treated rats.
    Turnquist J; Ornoy A; Eini D; Schwartz Z
    Acta Anat (Basel); 1992; 145(1):61-7. PubMed ID: 1414214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A double blind trial of alfacalcidol on patients with rheumatoid arthritis (RA)].
    Yamauchi Y; Tsunematsu T; Konda S; Hoshino T; Itokawa Y; Hoshizaki H
    Ryumachi; 1989 Feb; 29(1):11-24. PubMed ID: 2662431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiepileptics and bone atrophy--3-year follow-up study.
    Renri T; Ueda S; Anraku T; Satoh H; Tsujimaru S; Nakazawa Y; Ueda J
    Jpn J Psychiatry Neurol; 1990 Jun; 44(2):385-6. PubMed ID: 2259029
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
    Koo DL; Hwang KJ; Han SW; Kim JY; Joo EY; Shin WC; Lee HW; Seo DW; Hong SB
    Epilepsy Res; 2014 Mar; 108(3):442-7. PubMed ID: 24507862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of 1 alpha-OH-D3 on the bone metabolism after high tibial osteotomy].
    Yamashita I; Miyatsu M; Kamo Y; Atsuta Y; Onozawa T
    Nihon Seikeigeka Gakkai Zasshi; 1993 Sep; 67(9):804-15. PubMed ID: 8409641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of 1 alpha hydroxy vitamin D3 treatment of the metabolic bone disorder in patients who underwent gastrectomy for gastric cancer.
    Rino Y; Imada T; Yamamoto Y; Takahashi M; Amano T; Takanashi Y
    Hepatogastroenterology; 2000; 47(35):1498-500. PubMed ID: 11100386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of bone mineral density using digital image processing in children receiving anticonvulsants].
    Suzuki K; Ueda S; Umezu R; Matsuoka H; Sugihara S
    No To Hattatsu; 2007 Sep; 39(5):351-5. PubMed ID: 17879608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of VPA on bone: From clinical studies to cell cultures-The molecular mechanisms revisited.
    Pitetzis DA; Spilioti MG; Yovos JG; Yavropoulou MP
    Seizure; 2017 May; 48():36-43. PubMed ID: 28391043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of osteitis fibrosa, aluminium bone disease and soft-tissue calcification in dialysis patients: a long-term comparison of moderate doses of oral calcium +/- Mg(OH)2 vs Al(OH)3 +/- 1 alpha OH vitamin D3.
    Morinière P; Boudailliez B; Hocine C; Belbrik S; Renaud H; Westeel PF; Solal MC; Fournier A
    Nephrol Dial Transplant; 1989; 4(12):1045-53. PubMed ID: 2517325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.